Autor: "Wang N" - OpacWWW - Prolib Integro

Skocz do pozycji: 1.

Tytuł:: Developing liver-targeted naringenin nanoparticles for breast cancer endocrine therapy by promoting estrogen metabolism.
Autorzy:: Zhao Y; State Key Laboratory of Dampness, Syndrome of Chinese Medicine, The Second Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou University of Chinese Medicine, Guangzhou, Guangdong, China.
Tan H; The Research Center for Integrative Medicine, School of Basic Medical Sciences, Guangzhou University of Chinese Medicine, Guangzhou, Guangdong, China.
Zhang J; State Key Laboratory of Dampness, Syndrome of Chinese Medicine, The Second Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou University of Chinese Medicine, Guangzhou, Guangdong, China.; Guangdong-Hong Kong-Macau Joint Lab on Chinese Medicine and Immune Disease Research, Guangzhou University of Chinese Medicine, Guangzhou, Guangdong, China.
Zhan D; State Key Laboratory of Dampness, Syndrome of Chinese Medicine, The Second Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou University of Chinese Medicine, Guangzhou, Guangdong, China.
Yang B; State Key Laboratory of Dampness, Syndrome of Chinese Medicine, The Second Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou University of Chinese Medicine, Guangzhou, Guangdong, China.; Guangdong-Hong Kong-Macau Joint Lab on Chinese Medicine and Immune Disease Research, Guangzhou University of Chinese Medicine, Guangzhou, Guangdong, China.
Hong S; State Key Laboratory of Dampness, Syndrome of Chinese Medicine, The Second Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou University of Chinese Medicine, Guangzhou, Guangdong, China.
Pan B; State Key Laboratory of Dampness, Syndrome of Chinese Medicine, The Second Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou University of Chinese Medicine, Guangzhou, Guangdong, China.; Guangdong-Hong Kong-Macau Joint Lab on Chinese Medicine and Immune Disease Research, Guangzhou University of Chinese Medicine, Guangzhou, Guangdong, China.
Wang N; The Research Center for Integrative Medicine, School of Basic Medical Sciences, Guangzhou University of Chinese Medicine, Guangzhou, Guangdong, China.
Chen T; Science and Technology Innovation Center, Guangzhou University of Chinese Medicine, Guangzhou, Guangdong, China. .
Shi Y; The Research Center for Integrative Medicine, School of Basic Medical Sciences, Guangzhou University of Chinese Medicine, Guangzhou, Guangdong, China. .
Wang Z; State Key Laboratory of Dampness, Syndrome of Chinese Medicine, The Second Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou University of Chinese Medicine, Guangzhou, Guangdong, China. .; Guangdong-Hong Kong-Macau Joint Lab on Chinese Medicine and Immune Disease Research, Guangzhou University of Chinese Medicine, Guangzhou, Guangdong, China. .; Guangdong Provincial Key Laboratory of Clinical Research On Traditional Chinese Medicine Syndrome, Guangdong Provincial Hospital of Chinese Medicine, Guangdong Provincial Academy of Chinese Medical Sciences, Guangzhou, Guangdong, China. .; Pokaż więcej
Źródło:: Journal of nanobiotechnology [J Nanobiotechnology] 2024 Mar 19; Vol. 22 (1), pp. 122. Date of Electronic Publication: 2024 Mar 19.
Typ publikacji:: Journal Article
MeSH Terms:: Breast Neoplasms*/pathology
Nanoparticles*
Flavanones*
Humans ; Mice ; Animals ; Female ; Zebrafish/metabolism ; Receptors, Estrogen/metabolism ; Estrogens/metabolism ; Estrogens/therapeutic use ; Tamoxifen/pharmacology ; Estradiol/pharmacology ; Liver/metabolism

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 2.

Tytuł:: Prognostic nomograms for breast cancer with lung metastasis: a SEER-based population study.
Autorzy:: Xie Y; Department of Breast Surgery, The First Affiliated Hospital of Jinan University, Jinan University, Guangzhou, China.
Lei C; Department of Breast Surgery, The First Affiliated Hospital of Jinan University, Jinan University, Guangzhou, China.
Ma Y; Department of Breast Surgery, The First Affiliated Hospital of Jinan University, Jinan University, Guangzhou, China.
Li Y; Department of Breast Surgery, The First Affiliated Hospital of Jinan University, Jinan University, Guangzhou, China.
Yang M; Department of Breast Surgery, The First Affiliated Hospital of Jinan University, Jinan University, Guangzhou, China.
Zhang Y; Department of Breast Surgery, The First Affiliated Hospital of Jinan University, Jinan University, Guangzhou, China.
Law KN; Department of Breast Surgery, The First Affiliated Hospital of Jinan University, Jinan University, Guangzhou, China.
Wang N; Department of Breast Surgery, The First Affiliated Hospital of Jinan University, Jinan University, Guangzhou, China.
Qu S; Department of Breast Surgery, The First Affiliated Hospital of Jinan University, Jinan University, Guangzhou, China. .; Pokaż więcej
Źródło:: BMC women's health [BMC Womens Health] 2024 Jan 03; Vol. 24 (1), pp. 16. Date of Electronic Publication: 2024 Jan 03.
Typ publikacji:: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:: Breast Neoplasms*
Lung Neoplasms*/pathology
Female ; Humans ; Breast ; Neoplasm Staging ; Nomograms ; Prognosis ; Neoplasm Metastasis

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 3.

Tytuł:: [The expression of Plakoglobin in residual cancer after neoadjuvant chemotherapy for breast cancer and its prognostic impact on patients].
Autorzy:: Li Y; Department of Breast Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China.
Guo L; Department of Pathology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China.
Guo CY; Department of Pathology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China.
Lei CQ; Department of Breast Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China.
Zhang K; Department of Breast Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China.
Wang NC; Department of Cancer Prevention, Office of Cancer Screening, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China.
Wang ZZ; Department of Breast Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China.
Xuan LX; Department of Breast Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China.; Pokaż więcej
Źródło:: Zhonghua zhong liu za zhi [Chinese journal of oncology] [Zhonghua Zhong Liu Za Zhi] 2023 Dec 23; Vol. 45 (12), pp. 1057-1064.
Typ publikacji:: English Abstract; Journal Article
MeSH Terms:: Breast Neoplasms*/drug therapy
Breast Neoplasms*/surgery
Humans ; Female ; Prognosis ; Ki-67 Antigen/analysis ; Neoadjuvant Therapy/methods ; gamma Catenin ; Neoplasm, Residual ; Disease-Free Survival ; Retrospective Studies ; Antineoplastic Combined Chemotherapy Protocols/therapeutic use

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 4.

Tytuł:: Circ_0001387 regulates SKA2 to accelerate breast cancer progression through miR-136-5p.
Autorzy:: Xiong Y; Department of Breast Surgery, The First Affiliated Hospital of Zhengzhou University, Zhengzhou City, China.
Li L; Department of Breast Surgery, The First Affiliated Hospital of Zhengzhou University, Zhengzhou City, China.
Wang N; Department of Breast Surgery, The First Affiliated Hospital of Zhengzhou University, Zhengzhou City, China.
Wang F; Department of Breast Surgery, The First Affiliated Hospital of Zhengzhou University, Zhengzhou City, China.
Chen Z; Department of Breast Surgery, The First Affiliated Hospital of Zhengzhou University, Zhengzhou City, China.
Han L; Department of Breast Surgery, The First Affiliated Hospital of Zhengzhou University, Zhengzhou City, China.
Jiang S; Department of Breast Surgery, The First Affiliated Hospital of Zhengzhou University, Zhengzhou City, China.
Gu Y; Department of Breast Surgery, The First Affiliated Hospital of Zhengzhou University, Zhengzhou City, China.; Pokaż więcej
Źródło:: Thoracic cancer [Thorac Cancer] 2023 Jun; Vol. 14 (18), pp. 1707-1718. Date of Electronic Publication: 2023 May 02.
Typ publikacji:: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:: Breast Neoplasms*/genetics
MicroRNAs*/genetics
RNA, Circular*/genetics
Animals ; Female ; Humans ; Mice ; Apoptosis ; Breast ; Cell Movement ; Cell Proliferation ; Chromosomal Proteins, Non-Histone/genetics ; Disease Models, Animal

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 5.

Tytuł:: Chronic psychological stress promotes breast cancer pre-metastatic niche formation by mobilizing splenic MDSCs via TAM/CXCL1 signaling.
Autorzy:: Zheng Y; State Key Laboratory of Dampness Syndrome of Chinese Medicine, The Second Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, 510006, China.; Integrative Research Laboratory of Breast Cancer, Discipline of Integrated Chinese and Western Medicine, The Second Clinical College of Guangzhou University of Chinese Medicine, Guangzhou, Guangdong, 510006, China.; Guangdong-Hong Kong-Macau Joint Lab on Chinese Medicine and Immune Disease Research, Guangzhou University of Chinese Medicine, Guangzhou, Guangdong, 510006, China.
Wang N; Integrative Research Laboratory of Breast Cancer, Discipline of Integrated Chinese and Western Medicine, The Second Clinical College of Guangzhou University of Chinese Medicine, Guangzhou, Guangdong, 510006, China.; Guangdong-Hong Kong-Macau Joint Lab on Chinese Medicine and Immune Disease Research, Guangzhou University of Chinese Medicine, Guangzhou, Guangdong, 510006, China.; Guangdong Provincial Key Laboratory of Clinical Research on Traditional Chinese Medicine Syndrome, Guangdong Provincial Academy of Chinese Medical Sciences, Guangdong Provincial Hospital of Chinese Medicine, Guangzhou, Guangdong, 510006, China.; The Research Center for Integrative Medicine, School of Basic Medical Sciences, Guangzhou University of Chinese Medicine, Guangzhou, Guangdong, 510006, China.
Wang S; State Key Laboratory of Dampness Syndrome of Chinese Medicine, The Second Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, 510006, China.; Integrative Research Laboratory of Breast Cancer, Discipline of Integrated Chinese and Western Medicine, The Second Clinical College of Guangzhou University of Chinese Medicine, Guangzhou, Guangdong, 510006, China.; Guangdong-Hong Kong-Macau Joint Lab on Chinese Medicine and Immune Disease Research, Guangzhou University of Chinese Medicine, Guangzhou, Guangdong, 510006, China.; Guangdong Provincial Key Laboratory of Clinical Research on Traditional Chinese Medicine Syndrome, Guangdong Provincial Academy of Chinese Medical Sciences, Guangdong Provincial Hospital of Chinese Medicine, Guangzhou, Guangdong, 510006, China.
Zhang J; State Key Laboratory of Dampness Syndrome of Chinese Medicine, The Second Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, 510006, China.; Integrative Research Laboratory of Breast Cancer, Discipline of Integrated Chinese and Western Medicine, The Second Clinical College of Guangzhou University of Chinese Medicine, Guangzhou, Guangdong, 510006, China.; Guangdong-Hong Kong-Macau Joint Lab on Chinese Medicine and Immune Disease Research, Guangzhou University of Chinese Medicine, Guangzhou, Guangdong, 510006, China.
Yang B; State Key Laboratory of Dampness Syndrome of Chinese Medicine, The Second Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, 510006, China.; Integrative Research Laboratory of Breast Cancer, Discipline of Integrated Chinese and Western Medicine, The Second Clinical College of Guangzhou University of Chinese Medicine, Guangzhou, Guangdong, 510006, China.
Wang Z; State Key Laboratory of Dampness Syndrome of Chinese Medicine, The Second Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, 510006, China. .; Integrative Research Laboratory of Breast Cancer, Discipline of Integrated Chinese and Western Medicine, The Second Clinical College of Guangzhou University of Chinese Medicine, Guangzhou, Guangdong, 510006, China. .; Guangdong-Hong Kong-Macau Joint Lab on Chinese Medicine and Immune Disease Research, Guangzhou University of Chinese Medicine, Guangzhou, Guangdong, 510006, China. .; Guangdong Provincial Key Laboratory of Clinical Research on Traditional Chinese Medicine Syndrome, Guangdong Provincial Academy of Chinese Medical Sciences, Guangdong Provincial Hospital of Chinese Medicine, Guangzhou, Guangdong, 510006, China. .; The Research Center for Integrative Medicine, School of Basic Medical Sciences, Guangzhou University of Chinese Medicine, Guangzhou, Guangdong, 510006, China. .; Pokaż więcej
Źródło:: Journal of experimental & clinical cancer research : CR [J Exp Clin Cancer Res] 2023 May 20; Vol. 42 (1), pp. 129. Date of Electronic Publication: 2023 May 20.
Typ publikacji:: Journal Article
MeSH Terms:: Breast Neoplasms*/pathology
Melanoma*/pathology
Myeloid-Derived Suppressor Cells*
Stress, Psychological*/complications
Female ; Humans ; Chemokine CXCL1/metabolism ; Spleen/metabolism ; Spleen/pathology ; Tumor Microenvironment ; Melanoma, Cutaneous Malignant

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 6.

Tytuł:: A retrospective cohort study of tamoxifen versus surgical treatment for ER-positive gynecomastia.
Autorzy:: He W; Department of Breast Surgery, the First Affiliated Hospital of Jinan University, 510630, Guangzhou, China.
Wei W; Department of Breast Surgery, Sun Yat-sen University Cancer Center, 510630, Guangzhou, China.
Zhang Q; Department of Breast Surgery, the First Affiliated Hospital of Jinan University, 510630, Guangzhou, China.
Lv R; Department of Breast Surgery, the First Affiliated Hospital of Jinan University, 510630, Guangzhou, China.
Qu S; Department of Breast Surgery, the First Affiliated Hospital of Jinan University, 510630, Guangzhou, China.
Huang X; Department of Breast Surgery, the First Affiliated Hospital of Jinan University, 510630, Guangzhou, China.
Ma J; Department of Laboratory, the First Affiliated Hospital of Jinan University, 510630, Guangzhou, China.
Zhang P; Department of Ultrasonography, the First Affiliated Hospital of Jinan University, 510630, Guangzhou, China.
Zhai H; Department of Digestive Endoscopy c Center, the First/Fifth Affiliated Hospital of Jinan University, No. 613, Huangpu Avenue West, Tianhe District, 510630, Guangzhou, China. .
Wang N; Department of Breast Surgery, the First Affiliated Hospital of Jinan University, 510630, Guangzhou, China. .; Pokaż więcej
Źródło:: BMC endocrine disorders [BMC Endocr Disord] 2023 Mar 13; Vol. 23 (1), pp. 62. Date of Electronic Publication: 2023 Mar 13.
Typ publikacji:: Journal Article
MeSH Terms:: Gynecomastia*/surgery
Breast Neoplasms*/drug therapy
Male ; Humans ; Tamoxifen/therapeutic use ; Retrospective Studies ; Breast ; Estrogens

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 7.

Tytuł:: A Comprehensive Analysis Revealing FBXW9 as a Potential Prognostic and Immunological Biomarker in Breast Cancer.
Autorzy:: Yu S; Institute of Translational Medicine, Medical College, Yangzhou University, Yangzhou 225001, China.; Jiangsu Key Laboratory of Experimental & Translational Non-Coding RNA Research Yangzhou, Yangzhou 225001, China.
Liang Z; Institute of Translational Medicine, Medical College, Yangzhou University, Yangzhou 225001, China.; Jiangsu Key Laboratory of Experimental & Translational Non-Coding RNA Research Yangzhou, Yangzhou 225001, China.
Fan Z; Institute of Translational Medicine, Medical College, Yangzhou University, Yangzhou 225001, China.; Jiangsu Key Laboratory of Experimental & Translational Non-Coding RNA Research Yangzhou, Yangzhou 225001, China.
Cao B; Institute of Translational Medicine, Medical College, Yangzhou University, Yangzhou 225001, China.; Jiangsu Key Laboratory of Experimental & Translational Non-Coding RNA Research Yangzhou, Yangzhou 225001, China.
Wang N; Institute of Translational Medicine, Medical College, Yangzhou University, Yangzhou 225001, China.; Jiangsu Key Laboratory of Experimental & Translational Non-Coding RNA Research Yangzhou, Yangzhou 225001, China.
Wu R; Institute of Translational Medicine, Medical College, Yangzhou University, Yangzhou 225001, China.; Jiangsu Key Laboratory of Experimental & Translational Non-Coding RNA Research Yangzhou, Yangzhou 225001, China.
Sun H; Institute of Translational Medicine, Medical College, Yangzhou University, Yangzhou 225001, China.; Jiangsu Key Laboratory of Experimental & Translational Non-Coding RNA Research Yangzhou, Yangzhou 225001, China.; Pokaż więcej
Źródło:: International journal of molecular sciences [Int J Mol Sci] 2023 Mar 09; Vol. 24 (6). Date of Electronic Publication: 2023 Mar 09.
Typ publikacji:: Journal Article
MeSH Terms:: Breast Neoplasms*/genetics
Breast Neoplasms*/metabolism
F-Box Proteins*/genetics
F-Box Proteins*/metabolism
Female ; Humans ; Biomarkers ; Cell Line, Tumor ; Prognosis

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 8.

Tytuł:: Cefoselis enhances breast cancer chemosensitivity by directly targeting GRP78/LRP5 signalling of cancer stem cells.
Autorzy:: Zheng Y; Integrative Research Laboratory of Breast Cancer, Discipline of Integrated Chinese and Western Medicine, The Second Clinical College of Guangzhou University of Chinese Medicine, Guangzhou, Guangdong, China.; State Key Laboratory of Dampness Syndrome of Chinese Medicine, The Second Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, China.; Guangdong-Hong Kong-Macau Joint Lab on Chinese Medicine and Immune Disease Research, Guangzhou University of Chinese Medicine, Guangzhou, Guangdong, China.
Wang N; Integrative Research Laboratory of Breast Cancer, Discipline of Integrated Chinese and Western Medicine, The Second Clinical College of Guangzhou University of Chinese Medicine, Guangzhou, Guangdong, China.; State Key Laboratory of Dampness Syndrome of Chinese Medicine, The Second Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, China.; Guangdong Provincial Key Laboratory of Clinical Research on Traditional Chinese Medicine Syndrome, Guangdong Provincial Academy of Chinese Medical Sciences, Guangdong Provincial Hospital of Chinese Medicine, Guangzhou, Guangdong, China.; Guangdong-Hong Kong-Macau Joint Lab on Chinese Medicine and Immune Disease Research, Guangzhou University of Chinese Medicine, Guangzhou, Guangdong, China.; The Research Center for Integrative Medicine, School of Basic Medical Sciences, Guangzhou University of Chinese Medicine, Guangzhou, Guangdong, China.
Wang S; Integrative Research Laboratory of Breast Cancer, Discipline of Integrated Chinese and Western Medicine, The Second Clinical College of Guangzhou University of Chinese Medicine, Guangzhou, Guangdong, China.; State Key Laboratory of Dampness Syndrome of Chinese Medicine, The Second Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, China.; Guangdong Provincial Key Laboratory of Clinical Research on Traditional Chinese Medicine Syndrome, Guangdong Provincial Academy of Chinese Medical Sciences, Guangdong Provincial Hospital of Chinese Medicine, Guangzhou, Guangdong, China.; Guangdong-Hong Kong-Macau Joint Lab on Chinese Medicine and Immune Disease Research, Guangzhou University of Chinese Medicine, Guangzhou, Guangdong, China.
Pan B; Integrative Research Laboratory of Breast Cancer, Discipline of Integrated Chinese and Western Medicine, The Second Clinical College of Guangzhou University of Chinese Medicine, Guangzhou, Guangdong, China.; State Key Laboratory of Dampness Syndrome of Chinese Medicine, The Second Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, China.
Yang B; Integrative Research Laboratory of Breast Cancer, Discipline of Integrated Chinese and Western Medicine, The Second Clinical College of Guangzhou University of Chinese Medicine, Guangzhou, Guangdong, China.; State Key Laboratory of Dampness Syndrome of Chinese Medicine, The Second Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, China.
Zhang J; Integrative Research Laboratory of Breast Cancer, Discipline of Integrated Chinese and Western Medicine, The Second Clinical College of Guangzhou University of Chinese Medicine, Guangzhou, Guangdong, China.; State Key Laboratory of Dampness Syndrome of Chinese Medicine, The Second Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, China.; Guangdong-Hong Kong-Macau Joint Lab on Chinese Medicine and Immune Disease Research, Guangzhou University of Chinese Medicine, Guangzhou, Guangdong, China.
Wang X; Integrative Research Laboratory of Breast Cancer, Discipline of Integrated Chinese and Western Medicine, The Second Clinical College of Guangzhou University of Chinese Medicine, Guangzhou, Guangdong, China.; State Key Laboratory of Dampness Syndrome of Chinese Medicine, The Second Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, China.
Wang Z; Integrative Research Laboratory of Breast Cancer, Discipline of Integrated Chinese and Western Medicine, The Second Clinical College of Guangzhou University of Chinese Medicine, Guangzhou, Guangdong, China.; State Key Laboratory of Dampness Syndrome of Chinese Medicine, The Second Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, China.; Guangdong Provincial Key Laboratory of Clinical Research on Traditional Chinese Medicine Syndrome, Guangdong Provincial Academy of Chinese Medical Sciences, Guangdong Provincial Hospital of Chinese Medicine, Guangzhou, Guangdong, China.; Guangdong-Hong Kong-Macau Joint Lab on Chinese Medicine and Immune Disease Research, Guangzhou University of Chinese Medicine, Guangzhou, Guangdong, China.; The Research Center for Integrative Medicine, School of Basic Medical Sciences, Guangzhou University of Chinese Medicine, Guangzhou, Guangdong, China.; Pokaż więcej
Źródło:: Clinical and translational medicine [Clin Transl Med] 2023 Feb; Vol. 13 (2), pp. e1119.
Typ publikacji:: Letter; Research Support, Non-U.S. Gov't
MeSH Terms:: Breast Neoplasms*
Humans ; Female ; Endoplasmic Reticulum Chaperone BiP ; Ceftizoxime ; Neoplastic Stem Cells ; Low Density Lipoprotein Receptor-Related Protein-5

Raport

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 9.

Tytuł:: Identification of a combined apoptosis and hypoxia gene signature for predicting prognosis and immune infiltration in breast cancer.
Autorzy:: Ren X; Department of Oncology, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, China.
Cui H; Department of Oncology, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, China.
Wu J; Department of Oncology, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, China.
Zhou R; Department of Oncology, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, China.
Wang N; Department of Oncology, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, China.
Liu D; Department of Oncology, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, China.
Xie X; Department of Surgical Oncology, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, China.
Zhang H; Department of Surgical Oncology, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, China.
Liu D; Department of Oncology, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, China.
Ma X; Department of Oncology, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, China.
Dang C; Department of Surgical Oncology, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, China.
Kang H; Department of Oncology, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, China.
Lin S; Department of Oncology, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, China.; Pokaż więcej
Źródło:: Cancer medicine [Cancer Med] 2022 Oct; Vol. 11 (20), pp. 3886-3901. Date of Electronic Publication: 2022 Apr 20.
Typ publikacji:: Journal Article
MeSH Terms:: Breast Neoplasms*/genetics
Humans ; Female ; Prognosis ; Apoptosis/genetics ; Biomarkers ; Hypoxia ; RNA, Messenger/genetics ; Oncogene Proteins ; Cell Cycle Proteins

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 10.

Tytuł:: Identification of novel prognostic risk signature of breast cancer based on ferroptosis-related genes.
Autorzy:: Wang N; Department of Breast Surgery, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, 450052, Henan, People's Republic of China. .
Gu Y; Department of Breast Surgery, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, 450052, Henan, People's Republic of China.
Li L; Department of Breast Surgery, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, 450052, Henan, People's Republic of China.
Chi J; Department of Breast Surgery, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, 450052, Henan, People's Republic of China.
Liu X; Department of Breast Surgery, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, 450052, Henan, People's Republic of China.
Xiong Y; Department of Breast Surgery, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, 450052, Henan, People's Republic of China.
Jiang S; Department of Breast Surgery, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, 450052, Henan, People's Republic of China.
Zhang W; Department of Breast Surgery, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, 450052, Henan, People's Republic of China.
Zhong C; Department of Plastic Surgery, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, 450052, Henan, People's Republic of China.; Pokaż więcej
Źródło:: Scientific reports [Sci Rep] 2022 Aug 12; Vol. 12 (1), pp. 13766. Date of Electronic Publication: 2022 Aug 12.
Typ publikacji:: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:: Breast Neoplasms*/genetics
Breast Neoplasms*/pathology
Ferroptosis*/genetics
Biomarkers, Tumor/genetics ; Biomarkers, Tumor/metabolism ; Cohort Studies ; Female ; Humans ; Kaplan-Meier Estimate ; Prognosis ; Tumor Microenvironment

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 11.

Tytuł:: Aiduqing formula inhibits breast cancer metastasis by suppressing TAM/CXCL1-induced Treg differentiation and infiltration.
Autorzy:: Li J; The Research Center of Integrative Cancer Medicine, Discipline of Integrated Chinese and Western Medicine, The Second Clinical College of Guangzhou University of Chinese Medicine, Guangzhou, Guangdong, China.; Guangdong Provincial Key Laboratory of Clinical Research On Traditional Chinese Medicine Syndrome, Guangdong Provincial Academy of Chinese Medical Sciences, Guangdong Provincial Hospital of Chinese Medicine, Guangzhou, Guangdong, China.
Wang S; The Research Center of Integrative Cancer Medicine, Discipline of Integrated Chinese and Western Medicine, The Second Clinical College of Guangzhou University of Chinese Medicine, Guangzhou, Guangdong, China.; Guangdong Provincial Key Laboratory of Clinical Research On Traditional Chinese Medicine Syndrome, Guangdong Provincial Academy of Chinese Medical Sciences, Guangdong Provincial Hospital of Chinese Medicine, Guangzhou, Guangdong, China.; Guangdong-Hong Kong-Macau Joint Lab On Chinese Medicine and Immune Disease Research, Guangzhou University of Chinese Medicine, Guangzhou, Guangdong, China.
Wang N; The Research Center of Integrative Cancer Medicine, Discipline of Integrated Chinese and Western Medicine, The Second Clinical College of Guangzhou University of Chinese Medicine, Guangzhou, Guangdong, China.; Guangdong-Hong Kong-Macau Joint Lab On Chinese Medicine and Immune Disease Research, Guangzhou University of Chinese Medicine, Guangzhou, Guangdong, China.; The Research Center for Integrative Medicine, School of Basic Medical Sciences, Guangzhou University of Chinese Medicine, Guangzhou, Guangdong, China.
Zheng Y; The Research Center of Integrative Cancer Medicine, Discipline of Integrated Chinese and Western Medicine, The Second Clinical College of Guangzhou University of Chinese Medicine, Guangzhou, Guangdong, China.; Guangdong Provincial Key Laboratory of Clinical Research On Traditional Chinese Medicine Syndrome, Guangdong Provincial Academy of Chinese Medical Sciences, Guangdong Provincial Hospital of Chinese Medicine, Guangzhou, Guangdong, China.
Yang B; The Research Center of Integrative Cancer Medicine, Discipline of Integrated Chinese and Western Medicine, The Second Clinical College of Guangzhou University of Chinese Medicine, Guangzhou, Guangdong, China.; Guangdong Provincial Key Laboratory of Clinical Research On Traditional Chinese Medicine Syndrome, Guangdong Provincial Academy of Chinese Medical Sciences, Guangdong Provincial Hospital of Chinese Medicine, Guangzhou, Guangdong, China.
Wang X; The Research Center of Integrative Cancer Medicine, Discipline of Integrated Chinese and Western Medicine, The Second Clinical College of Guangzhou University of Chinese Medicine, Guangzhou, Guangdong, China.; Guangdong Provincial Key Laboratory of Clinical Research On Traditional Chinese Medicine Syndrome, Guangdong Provincial Academy of Chinese Medical Sciences, Guangdong Provincial Hospital of Chinese Medicine, Guangzhou, Guangdong, China.
Zhang J; The Research Center of Integrative Cancer Medicine, Discipline of Integrated Chinese and Western Medicine, The Second Clinical College of Guangzhou University of Chinese Medicine, Guangzhou, Guangdong, China.; Guangdong Provincial Key Laboratory of Clinical Research On Traditional Chinese Medicine Syndrome, Guangdong Provincial Academy of Chinese Medical Sciences, Guangdong Provincial Hospital of Chinese Medicine, Guangzhou, Guangdong, China.
Pan B; The Research Center of Integrative Cancer Medicine, Discipline of Integrated Chinese and Western Medicine, The Second Clinical College of Guangzhou University of Chinese Medicine, Guangzhou, Guangdong, China.; Guangdong Provincial Key Laboratory of Clinical Research On Traditional Chinese Medicine Syndrome, Guangdong Provincial Academy of Chinese Medical Sciences, Guangdong Provincial Hospital of Chinese Medicine, Guangzhou, Guangdong, China.
Wang Z; The Research Center of Integrative Cancer Medicine, Discipline of Integrated Chinese and Western Medicine, The Second Clinical College of Guangzhou University of Chinese Medicine, Guangzhou, Guangdong, China. .; Guangdong Provincial Key Laboratory of Clinical Research On Traditional Chinese Medicine Syndrome, Guangdong Provincial Academy of Chinese Medical Sciences, Guangdong Provincial Hospital of Chinese Medicine, Guangzhou, Guangdong, China. .; Guangdong-Hong Kong-Macau Joint Lab On Chinese Medicine and Immune Disease Research, Guangzhou University of Chinese Medicine, Guangzhou, Guangdong, China. .; The Research Center for Integrative Medicine, School of Basic Medical Sciences, Guangzhou University of Chinese Medicine, Guangzhou, Guangdong, China. .; State Key Laboratory of Dampness, Syndrome of Chinese Medicine, The Second Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, 510120, China. .; Pokaż więcej
Źródło:: Cell communication and signaling : CCS [Cell Commun Signal] 2021 Aug 30; Vol. 19 (1), pp. 89. Date of Electronic Publication: 2021 Aug 30.
Typ publikacji:: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:: Medicine, Chinese Traditional*
Antineoplastic Agents/*pharmacology
Breast Neoplasms/*drug therapy
Chemokine CXCL1/*genetics
Animals ; Antineoplastic Agents/chemistry ; Breast Neoplasms/genetics ; Breast Neoplasms/pathology ; CD4-Positive T-Lymphocytes/drug effects ; CD8-Positive T-Lymphocytes/drug effects ; Cell Differentiation/drug effects ; Cell Line, Tumor ; Cell Movement/drug effects ; Cell Proliferation/drug effects ; Humans ; Mice ; Neoplasm Metastasis ; T-Lymphocytes, Regulatory/drug effects ; Tumor Microenvironment/drug effects ; Tumor-Associated Macrophages/drug effects ; Xenograft Model Antitumor Assays

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 12.

Tytuł:: [Clinical features and prognostic analysis of female breast cancer in different diagnosed ages].
Autorzy:: Li H; Office of Cancer Screening, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China.
Zuo TT; Cancer Hospital of China Medical University, Liaoning Cancer Hospital & Institute, Shenyang 110042, China.
Zeng HM; Office of Cancer Registry, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China.
Zheng RS; Office of Cancer Registry, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China.
Yang L; Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Beijing Office for Cancer Prevention and Control, Peking University Cancer Hospital & Institute, Beijing 100142, China.
Li HC; Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Beijing Office for Cancer Prevention and Control, Peking University Cancer Hospital & Institute, Beijing 100142, China.
Liu S; Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Beijing Office for Cancer Prevention and Control, Peking University Cancer Hospital & Institute, Beijing 100142, China.
Yuan YN; Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Beijing Office for Cancer Prevention and Control, Peking University Cancer Hospital & Institute, Beijing 100142, China.
Wang N; Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Beijing Office for Cancer Prevention and Control, Peking University Cancer Hospital & Institute, Beijing 100142, China.
Chen WQ; Office of Cancer Screening, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China.; Pokaż więcej
Źródło:: Zhonghua zhong liu za zhi [Chinese journal of oncology] [Zhonghua Zhong Liu Za Zhi] 2021 Jan 23; Vol. 43 (1), pp. 126-131.
Typ publikacji:: Journal Article
MeSH Terms:: Breast Neoplasms*/diagnosis
Adult ; Aged ; Breast ; Female ; Humans ; Middle Aged ; Prognosis ; Proportional Hazards Models

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 13.

Tytuł:: CircNOL10 suppresses breast cancer progression by sponging miR-767-5p to regulate SOCS2/JAK/STAT signaling.
Autorzy:: Wang F; Department of Breast Surgery, The First Affiliated Hospital of Zhengzhou University, No.1 Jianshe East Road, Erqi, Zhengzhou, 450000, China.
Wang X; Department of Breast Surgery, Affiliated Hospital of Hebei University, Baoding, 071000, China.
Li J; Department of Breast Surgery, The First Affiliated Hospital of Zhengzhou University, No.1 Jianshe East Road, Erqi, Zhengzhou, 450000, China.
Lv P; Department of Breast Surgery, The First Affiliated Hospital of Zhengzhou University, No.1 Jianshe East Road, Erqi, Zhengzhou, 450000, China.
Han M; Department of Breast Surgery, The First Affiliated Hospital of Zhengzhou University, No.1 Jianshe East Road, Erqi, Zhengzhou, 450000, China.
Li L; Department of Breast Surgery, The First Affiliated Hospital of Zhengzhou University, No.1 Jianshe East Road, Erqi, Zhengzhou, 450000, China.
Chen Z; Department of Breast Surgery, The First Affiliated Hospital of Zhengzhou University, No.1 Jianshe East Road, Erqi, Zhengzhou, 450000, China.
Dong L; Department of Breast Surgery, The First Affiliated Hospital of Zhengzhou University, No.1 Jianshe East Road, Erqi, Zhengzhou, 450000, China.
Wang N; Department of Breast Surgery, The First Affiliated Hospital of Zhengzhou University, No.1 Jianshe East Road, Erqi, Zhengzhou, 450000, China.
Gu Y; Department of Breast Surgery, The First Affiliated Hospital of Zhengzhou University, No.1 Jianshe East Road, Erqi, Zhengzhou, 450000, China. .; Pokaż więcej
Źródło:: Journal of biomedical science [J Biomed Sci] 2021 Jan 04; Vol. 28 (1), pp. 4. Date of Electronic Publication: 2021 Jan 04.
Typ publikacji:: Journal Article
MeSH Terms:: Disease Progression*
Signal Transduction*/drug effects
Antineoplastic Agents/*pharmacology
Breast Neoplasms/*diet therapy
MicroRNAs/*metabolism
RNA, Circular/*pharmacology
Cell Line, Tumor ; Female ; Humans

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 14.

Tytuł:: Epithelioid hemangioma of breast mimicking malignancy: One trap during rapid frozen pathologic diagnosis.
Autorzy:: Ren H; Department of Pathology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.; Basic Medicine College of Zhengzhou University, Zhengzhou, China.
Wang N; Shanghai University of Traditional Chinese Medicine, Shanghai, China.
Zhao P; Department of Pathology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.; Basic Medicine College of Zhengzhou University, Zhengzhou, China.
Xu Y; Department of Pathology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.; Basic Medicine College of Zhengzhou University, Zhengzhou, China.
Huang H; Department of Pathology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.; Basic Medicine College of Zhengzhou University, Zhengzhou, China.
Liu Y; Department of Pathology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.; Basic Medicine College of Zhengzhou University, Zhengzhou, China.
Li W; Department of Pathology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.; Basic Medicine College of Zhengzhou University, Zhengzhou, China.
Li H; Department of Pathology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.; Basic Medicine College of Zhengzhou University, Zhengzhou, China.; Pokaż więcej
Źródło:: The breast journal [Breast J] 2020 Oct; Vol. 26 (10), pp. 2052-2053. Date of Electronic Publication: 2020 Jun 19.
Typ publikacji:: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:: Breast Neoplasms*/diagnostic imaging
Hemangioma*/diagnostic imaging
Diagnosis, Differential ; Female ; Humans

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 15.

Tytuł:: Using the axillary reverse mapping technique to screen breast cancer patients with a high risk of lymphedema.
Autorzy:: Liu S; Breast Center, Peking University People's Hospital, Beijing, China.
Wang N; Tianjin Medical University Cancer Institute and Hospital, Tianjin, China.
Gao P; Nuclear Medicine Department, Peking University People's Hospital, Beijing, China.
Liu P; Breast Center, Peking University People's Hospital, Beijing, China.
Yang H; Breast Center, Peking University People's Hospital, Beijing, China.
Xie F; Breast Center, Peking University People's Hospital, Beijing, China.
Wang S; Breast Center, Peking University People's Hospital, Beijing, China.
Liu M; Breast Center, Peking University People's Hospital, Beijing, China. .
Wang S; Breast Center, Peking University People's Hospital, Beijing, China. .; Pokaż więcej
Źródło:: World journal of surgical oncology [World J Surg Oncol] 2020 Jun 01; Vol. 18 (1), pp. 118. Date of Electronic Publication: 2020 Jun 01.
Typ publikacji:: Journal Article; Observational Study
MeSH Terms:: Breast Neoplasms/*pathology
Lymph Node Excision/*methods
Lymphedema/*diagnosis
Sentinel Lymph Node/*pathology
Sentinel Lymph Node Biopsy/*methods
Axilla ; Breast Neoplasms/diagnostic imaging ; Breast Neoplasms/surgery ; Female ; Humans ; Lymphatic Metastasis ; Lymphatic Vessels/diagnostic imaging ; Lymphatic Vessels/pathology ; Lymphatic Vessels/surgery ; Lymphedema/diagnostic imaging ; Lymphedema/etiology ; Lymphedema/prevention & control ; Middle Aged ; Prospective Studies ; Sentinel Lymph Node/surgery

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 16.

Tytuł:: XIAOPI formula inhibits the pre-metastatic niche formation in breast cancer via suppressing TAMs/CXCL1 signaling.
Autorzy:: Zheng Y; Integrative Research Laboratory of Breast Cancer, the Research Centre of Integrative Medicine, Discipline of Integrated Chinese and Western Medicine & The Second Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, 510006, Guangdong, China.; Guangdong Provincial Key Laboratory of Clinical Research on Traditional Chinese Medicine Syndrome, Guangdong Provincial Academy of Chinese Medical Sciences, Guangdong Provincial Hospital of Chinese Medicine, Guangzhou, 510006, Guangdong, China.
Wang N; Integrative Research Laboratory of Breast Cancer, the Research Centre of Integrative Medicine, Discipline of Integrated Chinese and Western Medicine & The Second Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, 510006, Guangdong, China.; College of Basic Medicine, Guangzhou University of Chinese Medicine, Guangzhou, 510006, Guangdong, China.
Wang S; Integrative Research Laboratory of Breast Cancer, the Research Centre of Integrative Medicine, Discipline of Integrated Chinese and Western Medicine & The Second Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, 510006, Guangdong, China.; Guangdong Provincial Key Laboratory of Clinical Research on Traditional Chinese Medicine Syndrome, Guangdong Provincial Academy of Chinese Medical Sciences, Guangdong Provincial Hospital of Chinese Medicine, Guangzhou, 510006, Guangdong, China.
Yang B; Integrative Research Laboratory of Breast Cancer, the Research Centre of Integrative Medicine, Discipline of Integrated Chinese and Western Medicine & The Second Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, 510006, Guangdong, China.; Guangdong Provincial Key Laboratory of Clinical Research on Traditional Chinese Medicine Syndrome, Guangdong Provincial Academy of Chinese Medical Sciences, Guangdong Provincial Hospital of Chinese Medicine, Guangzhou, 510006, Guangdong, China.
Situ H; Integrative Research Laboratory of Breast Cancer, the Research Centre of Integrative Medicine, Discipline of Integrated Chinese and Western Medicine & The Second Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, 510006, Guangdong, China.; Guangdong Provincial Key Laboratory of Clinical Research on Traditional Chinese Medicine Syndrome, Guangdong Provincial Academy of Chinese Medical Sciences, Guangdong Provincial Hospital of Chinese Medicine, Guangzhou, 510006, Guangdong, China.
Zhong L; School of Chinese Medicine, Hong Kong Baptist University, Hong Kong, Special Administrative Region, China.
Lin Y; Integrative Research Laboratory of Breast Cancer, the Research Centre of Integrative Medicine, Discipline of Integrated Chinese and Western Medicine & The Second Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, 510006, Guangdong, China. .; Guangdong Provincial Key Laboratory of Clinical Research on Traditional Chinese Medicine Syndrome, Guangdong Provincial Academy of Chinese Medical Sciences, Guangdong Provincial Hospital of Chinese Medicine, Guangzhou, 510006, Guangdong, China. .
Wang Z; Integrative Research Laboratory of Breast Cancer, the Research Centre of Integrative Medicine, Discipline of Integrated Chinese and Western Medicine & The Second Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, 510006, Guangdong, China. .; Guangdong Provincial Key Laboratory of Clinical Research on Traditional Chinese Medicine Syndrome, Guangdong Provincial Academy of Chinese Medical Sciences, Guangdong Provincial Hospital of Chinese Medicine, Guangzhou, 510006, Guangdong, China. .; College of Basic Medicine, Guangzhou University of Chinese Medicine, Guangzhou, 510006, Guangdong, China. .; School of Chinese Medicine, Hong Kong Baptist University, Hong Kong, Special Administrative Region, China. .; Pokaż więcej
Źródło:: Cell communication and signaling : CCS [Cell Commun Signal] 2020 Mar 26; Vol. 18 (1), pp. 48. Date of Electronic Publication: 2020 Mar 26.
Typ publikacji:: Journal Article; Research Support, Non-U.S. Gov't; Video-Audio Media
MeSH Terms:: Breast Neoplasms*/drug therapy
Breast Neoplasms*/pathology
Lung Neoplasms*/drug therapy
Lung Neoplasms*/secondary
Plant Extracts*/administration & dosage
Plant Extracts*/pharmacology
Chemokine CXCL1/*metabolism
Tumor-Associated Macrophages/*metabolism
Animals ; Antineoplastic Agents/administration & dosage ; Antineoplastic Agents/pharmacology ; Cell Proliferation ; Female ; Mice ; Mice, Inbred BALB C ; RAW 264.7 Cells ; Tumor Microenvironment ; Tumor-Associated Macrophages/cytology

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 17.

Tytuł:: Preoperative Prediction of Axillary Lymph Node Metastasis in Breast Cancer using Radiomics Features of DCE-MRI.
Autorzy:: Cui X; Northeastern University, Sino-Dutch Biomedical and Information Engineering School, Wisdom Street, Shenyang, 110819, China.
Wang N; Northeastern University, Sino-Dutch Biomedical and Information Engineering School, Wisdom Street, Shenyang, 110819, China.
Zhao Y; Northeastern University, Sino-Dutch Biomedical and Information Engineering School, Wisdom Street, Shenyang, 110819, China.
Chen S; Northeastern University, Sino-Dutch Biomedical and Information Engineering School, Wisdom Street, Shenyang, 110819, China.
Li S; Radiology Department, The first hospital of China Medical University, 155# North Nanjing street, Heping district, Shenyang, 110001, China.
Xu M; Northeastern University, Sino-Dutch Biomedical and Information Engineering School, Wisdom Street, Shenyang, 110819, China.
Chai R; Radiology Department, The first hospital of China Medical University, 155# North Nanjing street, Heping district, Shenyang, 110001, China. .; Pokaż więcej
Źródło:: Scientific reports [Sci Rep] 2019 Feb 19; Vol. 9 (1), pp. 2240. Date of Electronic Publication: 2019 Feb 19.
Typ publikacji:: Journal Article; Research Support, Non-U.S. Gov't; Validation Study
MeSH Terms:: Magnetic Resonance Imaging*
Preoperative Period*
Breast Neoplasms/*diagnostic imaging
Adult ; Female ; Humans ; Lymphatic Metastasis ; Middle Aged

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 18.

Tytuł:: Parathyroid Hormone (PTH) Increases Skeletal Tumour Growth and Alters Tumour Distribution in an In Vivo Model of Breast Cancer.
Autorzy:: Brown HK; Department of Oncology and Metabolism, Mellanby Centre for Bone Research, University of Sheffield, Sheffield S10 2RX, UK. .
Allocca G; Department of Oncology and Metabolism, Mellanby Centre for Bone Research, University of Sheffield, Sheffield S10 2RX, UK. .
Ottewell PD; Department of Oncology and Metabolism, Mellanby Centre for Bone Research, University of Sheffield, Sheffield S10 2RX, UK. .
Wang N; Department of Oncology and Metabolism, Mellanby Centre for Bone Research, University of Sheffield, Sheffield S10 2RX, UK. N.Wang@sheffield.ac.uk.
Brown NJ; Department of Oncology and Metabolism, Mellanby Centre for Bone Research, University of Sheffield, Sheffield S10 2RX, UK. N..
Croucher PI; Bone Biology Division, Garvan Institute of Medical Research, Sydney, NSW 2010, Australia. .
Eaton CL; Department of Oncology and Metabolism, Mellanby Centre for Bone Research, University of Sheffield, Sheffield S10 2RX, UK. .
Holen I; Department of Oncology and Metabolism, Mellanby Centre for Bone Research, University of Sheffield, Sheffield S10 2RX, UK. .; Pokaż więcej
Źródło:: International journal of molecular sciences [Int J Mol Sci] 2018 Sep 26; Vol. 19 (10). Date of Electronic Publication: 2018 Sep 26.
Typ publikacji:: Journal Article
MeSH Terms:: Bone and Bones/*drug effects
Breast Neoplasms/*pathology
Osteoblasts/*drug effects
Parathyroid Hormone/*pharmacology
Animals ; Apoptosis/drug effects ; Bone and Bones/pathology ; Cell Line, Tumor ; Female ; Humans ; Mice, Inbred BALB C ; Mice, Nude ; Microscopy, Fluorescence, Multiphoton ; Tibia/drug effects ; Tibia/pathology ; Transplantation, Heterologous

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 19.

Tytuł:: Circulating HOTAIR expression predicts the clinical response to neoadjuvant chemotherapy in patients with breast cancer.
Autorzy:: Lu R; Department of Breast Surgery, The First Affiliated Hospital of Jinan University, Jinan University, Tianhe District, Guangzhou, Guangdong, China.; Department of Breast Surgery, The First Affiliated Hospital of Jinan University, Jinan University, Tianhe District, Guangzhou, Guangdong, China.
Zhang J; Department of Reproductive Medical Center, Guangdong Women and Children Hospital, Panyu District, Guangzhou, Guangdong, China.; Department of Breast Surgery, The First Affiliated Hospital of Jinan University, Jinan University, Tianhe District, Guangzhou, Guangdong, China.
Zhang W; Department of Breast Surgery, The First Affiliated Hospital of Jinan University, Jinan University, Tianhe District, Guangzhou, Guangdong, China.
Huang Y; Department of Breast Surgery, The First Affiliated Hospital of Jinan University, Jinan University, Tianhe District, Guangzhou, Guangdong, China.
Wang N; Department of Breast Surgery, The First Affiliated Hospital of Jinan University, Jinan University, Tianhe District, Guangzhou, Guangdong, China.
Zhang Q; Department of Breast Surgery, The First Affiliated Hospital of Jinan University, Jinan University, Tianhe District, Guangzhou, Guangdong, China.
Qu S; Department of Breast Surgery, The First Affiliated Hospital of Jinan University, Jinan University, Tianhe District, Guangzhou, Guangdong, China.; Pokaż więcej
Źródło:: Cancer biomarkers : section A of Disease markers [Cancer Biomark] 2018; Vol. 22 (2), pp. 249-256.
Typ publikacji:: Journal Article
MeSH Terms:: Cell-Free Nucleic Acids*
Gene Expression Regulation, Neoplastic*
Breast Neoplasms/*blood
Breast Neoplasms/*genetics
RNA, Long Noncoding/*genetics
Adult ; Aged ; Antineoplastic Combined Chemotherapy Protocols/adverse effects ; Antineoplastic Combined Chemotherapy Protocols/therapeutic use ; Biomarkers ; Breast Neoplasms/diagnosis ; Breast Neoplasms/therapy ; Combined Modality Therapy ; Female ; Humans ; Middle Aged ; Neoadjuvant Therapy ; Neoplasm Grading ; Neoplasm Metastasis ; Neoplasm Staging ; Prognosis ; RNA, Long Noncoding/blood ; Recurrence ; Survival Analysis ; Treatment Outcome

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 20.

Tytuł:: Direct inhibition of ACTN4 by ellagic acid limits breast cancer metastasis via regulation of β-catenin stabilization in cancer stem cells.
Autorzy:: Wang N; Department of Breast Oncology, Sun Yat-sen University Cancer Center; State Key Laboratory of Oncology in South China; Collaborative Innovation Center of Cancer Medicine, Guangzhou, People's Republic of China.; Guangdong Provincial Hospital of Chinese Medicine, The Second Clinical Medical College & The Research Center of Integrative Medicine, Guangzhou University of Chinese Medicine, Guangzhou Shi, China.
Wang Q; Guangdong Provincial Hospital of Chinese Medicine, The Second Clinical Medical College & The Research Center of Integrative Medicine, Guangzhou University of Chinese Medicine, Guangzhou Shi, China.
Tang H; Department of Breast Oncology, Sun Yat-sen University Cancer Center; State Key Laboratory of Oncology in South China; Collaborative Innovation Center of Cancer Medicine, Guangzhou, People's Republic of China.
Zhang F; Guangdong Provincial Hospital of Chinese Medicine, The Second Clinical Medical College & The Research Center of Integrative Medicine, Guangzhou University of Chinese Medicine, Guangzhou Shi, China.
Zheng Y; Guangdong Provincial Hospital of Chinese Medicine, The Second Clinical Medical College & The Research Center of Integrative Medicine, Guangzhou University of Chinese Medicine, Guangzhou Shi, China.
Wang S; Guangdong Provincial Hospital of Chinese Medicine, The Second Clinical Medical College & The Research Center of Integrative Medicine, Guangzhou University of Chinese Medicine, Guangzhou Shi, China.
Zhang J; Guangdong Provincial Hospital of Chinese Medicine, The Second Clinical Medical College & The Research Center of Integrative Medicine, Guangzhou University of Chinese Medicine, Guangzhou Shi, China.
Wang Z; Guangdong Provincial Hospital of Chinese Medicine, The Second Clinical Medical College & The Research Center of Integrative Medicine, Guangzhou University of Chinese Medicine, Guangzhou Shi, China. .
Xie X; Department of Breast Oncology, Sun Yat-sen University Cancer Center; State Key Laboratory of Oncology in South China; Collaborative Innovation Center of Cancer Medicine, Guangzhou, People's Republic of China. .; Pokaż więcej
Źródło:: Journal of experimental & clinical cancer research : CR [J Exp Clin Cancer Res] 2017 Dec 02; Vol. 36 (1), pp. 172. Date of Electronic Publication: 2017 Dec 02.
Typ publikacji:: Journal Article
MeSH Terms:: Actinin/*antagonists & inhibitors
Breast Neoplasms/*drug therapy
Ellagic Acid/*pharmacology
Neoplastic Stem Cells/*drug effects
beta Catenin/*metabolism
Actinin/biosynthesis ; Actinin/genetics ; Animals ; Breast Neoplasms/genetics ; Breast Neoplasms/metabolism ; Breast Neoplasms/pathology ; Cell Line, Tumor ; Cell Proliferation/drug effects ; Female ; Humans ; Lung Neoplasms/drug therapy ; Lung Neoplasms/secondary ; MCF-7 Cells ; Mice ; Mice, Transgenic ; Neoplasm Metastasis ; Neoplastic Stem Cells/metabolism ; Neoplastic Stem Cells/pathology ; Random Allocation ; Transfection ; Xenograft Model Antitumor Assays

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Informacja

Wyszukujesz frazę ""Wang N"" wg kryterium: Autor

Źródło danych

Ogranicz do:

Ogranicz do bazy

Typ dokumentu

Temat

Wydawca

Publikacja

Język